The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 418.10
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (0.048%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 418.10
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

25 Sep 2012 07:00

RNS Number : 0548N
Rentokil Initial PLC
25 September 2012
 



 

 

 

25 September 2012

 

Rentokil Initial acquires the assets of Western Exterminator Company

 

Rentokil Initial plc ("Rentokil") (LSE: RTO) today announces that it has agreed to acquire the assets of Western Exterminator Company ("Western"), a leading pest control company on the US West Coast, for an initial cash consideration of $99.6m, with a deferred consideration of up to $15.0m payable within 18 months, from existing financial facilities.

 

Rentokil will become the third largest pest control company in the North American market with pro-forma annualised revenues of $330m in pest control services (with coast to coast coverage) and $90m in speciality chemical products distribution.

 

Western has two divisions:

 

·; The Pest Control division has 36 offices located primarily in California and the adjacent states of Arizona and Nevada. It provides Rentokil with an entrance into these states with a population of 46m people.

 

·; The Products division is a leading wholesale distributor of specialty chemicals serving the West Coast and central regions of the US, providing products and supplies to the pest control, landscape, golf course and nursery industries. This division complements our existing specialty chemical products division which serves the East Coast of the US.

 

The acquisition is consistent with Rentokil's strategy, outlined in November 2011, of targeting pest control acquisitions in North America, Latin America and the Middle East.

 

The total book value of the gross assets to be acquired is $36.7m. In the year to 31 December 2011 the business acquired generated EBITA of $4.1m on revenues of approximately $149.0m (60% Pest Control: 40% Products).

 

The deferred consideration will be payable subject to certain working capital and other adjustments, including warranty and/or indemnity claims.

 

The acquisition is expected to complete later this year subject to receipt of the relevant regulatory clearances. The transaction will be EPS accretive in year one. The profitability of Western will be improved significantly by leveraging Rentokil's commercial and operational management capabilities to bring Western's operating margins into line with Rentokil's current North American Pest Control business.

 

Alan Brown, Chief Executive of Rentokil Initial plc, said:

 

"This acquisition significantly increases Rentokil's footprint in the World's largest pest control market and enables us to compete more effectively, particularly for customers looking for nationwide coverage in pest control or specialty chemical distribution capability.

 

"Western has service and quality levels that are among the best in the industry. It is rightly proud of its 90-year tradition and reputation.

 

"We have taken our US Pest Control and Products business from revenue of less than $30million to $420million through a series of successful acquisitions, most notably JC Ehrlich, Presto-X and now Western over the last seven years."

 

Ends

Note: A presentation with additional information about Western Exterminator can be found at www.rentokil-initial.com/investors/presentations

 

About Rentokil Initial plc

 

Rentokil Initial is one of the largest business services companies in the world, operating in all the major economies of Europe, North America, Asia Pacific and Africa. The Company has some 66,000 employees providing a range of support services in over 60 countries.

 

www.rentokil-initial.com

 

www.westernexterminator.com

 

www.target-specialty.com

 

 

Enquiries:

 

Investors / Analysts enquiries:

Katharine Rycroft, Head of Investor Relations Rentokil Initial plc 01293 858 166

 

Media enquiries:

Malcolm Padley, Corporate Communications Rentokil Initial plc 07788 978 199

Kate Holgate/ Catriona McDermott Brunswick Group 020 7404 5959

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUVUSRUWAKURR
Date   Source Headline
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes
10th Nov 20232:28 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:26 pmRNSHolding(s) in Company
3rd Nov 20234:22 pmRNSDirector/PDMR Shareholding
1st Nov 202312:50 pmRNSHolding(s) in Company
31st Oct 202311:45 amRNSHolding(s) in Company
30th Oct 20233:03 pmRNSDirector/PDMR Shareholding
30th Oct 202311:55 amRNSCredit rating update
19th Oct 20237:00 amRNSQ3 Trading Update
2nd Oct 202311:35 amRNSBlock listing Interim Review
27th Sep 20232:35 pmRNSDirector/PDMR Shareholding
1st Aug 202312:42 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNS2023 Interim Results
29th Jun 20239:00 amRNSNotice of Management Presentation
23rd Jun 20235:58 pmRNSDirector/PDMR Shareholding
19th May 20233:03 pmRNSDirector/PDMR Shareholding
12th May 20239:09 amRNSDirector/PDMR Shareholding
11th May 20239:17 amRNSResult of AGM
28th Apr 202310:55 amRNSHolding(s) in Company
21st Apr 20232:41 pmRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSQ1 Trading Update
4th Apr 20239:37 amRNSAnnual Financial Report
3rd Apr 202310:08 amRNSBlock listing Interim Review
23rd Mar 20239:42 amRNSDirector/PDMR Shareholding
20th Mar 20234:47 pmRNSDirector/PDMR Shareholding
16th Mar 20237:05 amRNSDirectorate Change
16th Mar 20237:00 amRNSFinal Results
9th Mar 20239:23 amRNSDirector Declaration
27th Feb 20238:55 amRNSNotice of Management Presentation
9th Nov 20224:33 pmRNSDirector Declaration
1st Nov 20222:25 pmRNSCorrection: Q3 Trading Update
1st Nov 20227:00 amRNSQ3 Trading Update
31st Oct 20224:03 pmRNSTotal Voting Rights
24th Oct 20225:15 pmRNSHolding(s) in Company
21st Oct 20224:42 pmRNSHolding(s) in Company
20th Oct 202212:35 pmRNSHolding(s) in Company
19th Oct 202211:43 amRNSHolding(s) in Company
18th Oct 20225:22 pmRNSHolding(s) in Company
17th Oct 20226:07 pmRNSHolding(s) in Company
17th Oct 202211:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.